BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33156106)

  • 1. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines.
    Wani S; Williams JL; Falk GW; Komanduri S; Muthusamy VR; Shaheen NJ
    Am J Gastroenterol; 2020 Nov; 115(11):1869-1878. PubMed ID: 33156106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-Utilization of Repeat Upper Endoscopy in Patients with Non-dysplastic Barrett's Esophagus: A Quality Registry Study.
    Wani S; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ
    Am J Gastroenterol; 2019 Aug; 114(8):1256-1264. PubMed ID: 30865017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative surveillance endoscopy occurs frequently in patients with short-segment non-dysplastic Barrett's esophagus.
    Melson J; Desai V; Greenspan M; Yau S; Abdalla M; Dhanekula R; Mobarhan S; Shapiro D; Losurdo J; Jakate S
    Dis Esophagus; 2015 Oct; 28(7):660-5. PubMed ID: 24943293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Disparities in Adherence to Quality Indicators in Barrett's Esophagus: An Analysis Using the GIQuIC National Benchmarking Registry.
    Jones B; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ; Wani S
    Am J Gastroenterol; 2021 Jun; 116(6):1201-1210. PubMed ID: 33767105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
    Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
    Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.
    Pilonis ND; Killcoyne S; Tan WK; O'Donovan M; Malhotra S; Tripathi M; Miremadi A; Debiram-Beecham I; Evans T; Phillips R; Morris DL; Vickery C; Harrison J; di Pietro M; Ortiz-Fernandez-Sordo J; Haidry R; Kerridge A; Sasieni PD; Fitzgerald RC
    Lancet Oncol; 2022 Feb; 23(2):270-278. PubMed ID: 35030332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus.
    Tavakkoli A; Appelman HD; Beer DG; Madiyal C; Khodadost M; Nofz K; Metko V; Elta G; Wang T; Rubenstein JH
    Clin Gastroenterol Hepatol; 2018 Jun; 16(6):862-869.e3. PubMed ID: 29432922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.
    Crockett SD; Lipkus IM; Bright SD; Sampliner RE; Wang KK; Boolchand V; Lutzke LS; Shaheen NJ
    Gastrointest Endosc; 2012 Jan; 75(1):23-31.e2. PubMed ID: 22100301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopists systematically undersample patients with long-segment Barrett's esophagus: an analysis of biopsy sampling practices from a quality improvement registry.
    Wani S; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ
    Gastrointest Endosc; 2019 Nov; 90(5):732-741.e3. PubMed ID: 31085185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus: an audit of surveillance over a 17-year period.
    Gladman L; Chapman W; Iqbal TH; Gearty JC; Cooper BT
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):271-6. PubMed ID: 16462540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up.
    Itskoviz D; Levi Z; Boltin D; Vilkin A; Snir Y; Gingold-Belfer R; Niv Y; Dotan I; Dickman R
    Dig Dis Sci; 2018 Jun; 63(6):1513-1517. PubMed ID: 29327262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice.
    Beg S; Mensa M; Fullard M; Finerty E; Richman P; Leahy A
    Gastrointest Endosc; 2018 May; 87(5):1189-1194. PubMed ID: 28958906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GIQuIC National Quality Benchmarking Registry.
    Kolb JM; Davis C; Williams JL; Holub J; Shaheen N; Wani S
    Am J Gastroenterol; 2023 May; 118(5):900-904. PubMed ID: 36623168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
    Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
    Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
    Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy.
    Omar M; Thaker AM; Wani S; Simon V; Ezekwe E; Boniface M; Edmundowicz S; Obuch J; Cinnor B; Brauer BC; Wood M; Early DS; Lang GD; Mullady D; Hollander T; Kushnir V; Komanduri S; Muthusamy VR
    Gastrointest Endosc; 2019 Sep; 90(3):395-403. PubMed ID: 31004598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Weusten BLAM; Bisschops R; Dinis-Ribeiro M; di Pietro M; Pech O; Spaander MCW; Baldaque-Silva F; Barret M; Coron E; Fernández-Esparrach G; Fitzgerald RC; Jansen M; Jovani M; Marques-de-Sa I; Rattan A; Tan WK; Verheij EPD; Zellenrath PA; Triantafyllou K; Pouw RE
    Endoscopy; 2023 Dec; 55(12):1124-1146. PubMed ID: 37813356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.